{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:20:10Z","timestamp":1785860410140,"version":"3.56.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Disease"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>X-linked chronic granulomatous disease (X-CGD) is a rare genetic immunodeficiency, predominantly affecting males. It leads to defective neutrophil function and increased susceptibility to infections, particularly nontuberculous mycobacteria and fungi. Early diagnosis is challenging due to its nonspecific symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 1-year-5-month-old male presented with recurrent lymphadenopathy, erythematous and ulcerative skin lesions, and persistent fever. These symptoms, along with pulmonary involvement, raised concerns for infectious diseases, leading to a misdiagnosis of tuberculosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      Genetic testing revealed a hemizygous mutation in the CYBB gene, confirming the diagnosis of X-CGD. Further investigations identified\n                      <jats:italic toggle=\"yes\">Mycobacterium gordonae<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Candida parapsilosis<\/jats:italic>\n                      as the causative pathogens.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient received broad-spectrum antibiotics and antifungal therapy, including meropenem, clarithromycin, linezolid, and voriconazole. Immunomodulatory treatments, including intravenous immunoglobulin and interferon-\u03b3, were initiated to support immune function. Hematopoietic stem cell transplantation was planned for long-term management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient showed significant improvement, with regression of cervical and pulmonary lesions. Ongoing recovery was observed, with plans for stem cell transplantation to achieve a potential cure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>X-CGD should be suspected in cases with recurrent infections and unusual responses to treatment. Genetic testing is essential for confirmation, and early initiation of prophylactic and targeted therapies can improve outcomes. Awareness of atypical presentations is crucial for timely diagnosis and intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046453","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T21:01:29Z","timestamp":1766782889000},"page":"e46453","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["X-linked chronic granulomatous disease combined with disseminated nontuberculous mycobacteria and fungal infections: Diagnosis and treatment analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Wenyuan","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6985-6952","authenticated-orcid":false,"given":"Xianming","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Lanxi Hospital of Traditional Chinese Medicine, Lanxi, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251226","first-page":"41","article-title":"Clinical features and CYBB mutation analysis in children with X-linked recessive chronic granulomatous disease.","volume":"29","author":"Jianxin","year":"2011","journal-title":"J Chin Clin Pediatr"},{"issue":"suppl_1","key":"R2-20251226","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1093\/jpids\/piy008","article-title":"Chronic granulomatous disease: epidemiology, pathophysiology, and genetic basis of disease.","volume":"7","author":"Rider","year":"2018","journal-title":"J. Pediatric Infect. Dis. Soc"},{"key":"R3-20251226","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification.","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"key":"R4-20251226","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mycmed.2011.12.079","article-title":"Fungal infection and increased mortality in patients with chronic granulomatous disease.","volume":"22","author":"Bassiri-Jahromi","year":"2012","journal-title":"J Mycol Med"},{"key":"R5-20251226","doi-asserted-by":"crossref","first-page":"151832","DOI":"10.1016\/j.anndiagpath.2021.151832","article-title":"Granulomatous fungal and non-tuberculous mycobacterial infestation complicating chronic lung disease: outcomes in patients undergoing lung transplantation.","volume":"55","author":"Sadaf","year":"2021","journal-title":"Ann Diagn Pathol"},{"key":"R6-20251226","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/QCO.0b013e328358b0a4","article-title":"Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management.","volume":"25","author":"Falcone","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"R7-20251226","doi-asserted-by":"crossref","first-page":"e01323","DOI":"10.1016\/j.idcr.2021.e01323","article-title":"Pneumocystis jirovecii pneumonia in a X-linked chronic granulomatous disease female carrier.","volume":"26","author":"Kalotychou","year":"2021","journal-title":"Idcases"},{"key":"R8-20251226","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaip.2016.03.021","article-title":"A comprehensive approach to the management of children and adults with chronic granulomatous disease.","volume":"4","author":"Thomsen","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R9-20251226","first-page":"877","article-title":"Study progress of chronic granulomatous disease in children.","volume":"35","author":"Yu","year":"2020","journal-title":"Chin J Appl Clin Pediatr"},{"key":"R10-20251226","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/bmb\/ldw009","article-title":"Chronic granulomatous disease.","volume":"118","author":"Roos","year":"2016","journal-title":"Br Med Bull"},{"key":"R11-20251226","doi-asserted-by":"crossref","first-page":"625320","DOI":"10.3389\/fimmu.2021.625320","article-title":"Clinical, immunological, and molecular profile of chronic granulomatous disease: a multi-centric study of 236 patients from India.","volume":"12","author":"Rawat","year":"2021","journal-title":"Front Immunol"},{"key":"R12-20251226","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/pai.13033","article-title":"Clinical and genetic characteristics of Chinese pediatric patients with chronic granulomatous disease.","volume":"30","author":"Gao","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"R13-20251226","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12016-020-08800-x","article-title":"Chronic granulomatous disease: a comprehensive review.","volume":"61","author":"Yu","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"R14-20251226","doi-asserted-by":"crossref","first-page":"803763","DOI":"10.3389\/fimmu.2021.803763","article-title":"Phenomic analysis of chronic granulomatous disease reveals more severe integumentary infections in X-linked compared with autosomal recessive chronic granulomatous disease.","volume":"12","author":"Chiu","year":"2021","journal-title":"Front Immunol"},{"key":"R15-20251226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.2000.01314.x","article-title":"Chronic granulomatous disease.","volume":"122","author":"Goldblatt","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"R16-20251226","doi-asserted-by":"crossref","first-page":"232","DOI":"10.29262\/ram.v66i2.577","article-title":"Chronic granulomatous disease. Update and review.","volume":"66","author":"L\u00f3pez-Hern\u00e1ndez","year":"2019","journal-title":"Rev Alerg Mex"},{"key":"R17-20251226","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","article-title":"Lentiviral gene therapy for X-linked chronic granulomatous disease.","volume":"26","author":"Kohn","year":"2020","journal-title":"Nat Med"},{"key":"R18-20251226","doi-asserted-by":"crossref","first-page":"102587","DOI":"10.1016\/j.bcmd.2021.102587","article-title":"Hematologically important mutations: X-linked chronic granulomatous disease (fourth update).","volume":"90","author":"Roos","year":"2021","journal-title":"Blood Cells Mol Dis"},{"key":"R19-20251226","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jaci.2013.05.039","article-title":"Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.","volume":"132","author":"K\u00f6ker","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl_1","key":"R20-20251226","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/jpids\/piy016","article-title":"Prevention of infectious complications in patients with chronic granulomatous disease.","volume":"7","author":"Slack","year":"2018","journal-title":"J. Pediatric Infect. Dis. Soc"},{"key":"R21-20251226","doi-asserted-by":"crossref","first-page":"e1080416","DOI":"10.1080\/2162402X.2015.1080416","article-title":"Interferon gamma\/NADPH oxidase defense system in immunity and cancer.","volume":"5","author":"Hodny","year":"2016","journal-title":"Oncoimmunology"},{"key":"R22-20251226","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pedneo.2024.02.008","article-title":"Chronic granulomatous disease: a single-center experience in Central Anatolia.","volume":"66","author":"Gul","year":"2025","journal-title":"Pediatr Neonatol"},{"key":"R23-20251226","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2174\/1566523214666140918113201","article-title":"Gene therapy for chronic granulomatous disease: current status and future perspectives.","volume":"14","author":"Kaufmann","year":"2014","journal-title":"Curr Gene Ther"},{"key":"R24-20251226","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1067\/mpd.2000.109112","article-title":"Long-term follow-up and outcome of 39 patients with chronic granulomatous disease.","volume":"137","author":"Liese","year":"2000","journal-title":"J Pediatr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:24:09Z","timestamp":1785857049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":24,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046453","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"2025-05-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}